Vicarious Surgical Inc. (RBOT) Tops Q3 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Vicarious Surgical Reports Third Quarter 2023 Financial Results
November 13, 2023 4:05 PM ESTWALTHAM, Mass.--(BUSINESS WIRE)-- Vicarious Surgical Inc. (Vicarious Surgical or the Company) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced financial results for the quarter ended September 30, 2023. Management will host a corresponding conference call at 4:30 p.m. ET today, November 13, 2023.
The third quarter brought several successes for our business, but also introduced new challenges as we focused on the build and integration of our Version 1.0 System, said Adam Sachs, Co-Founder and Chief Executive Officer. While we were pleased with our... More
